| (+)-3R,5S-Fluvastatin; (-)-3S,5R-Fluvastatin |
LC/MS/MS |
1-300 ng/mL |
Human EDTA Plasma |
Current |
Fluvastatin; S, R Fluvastatin |
| 6-Beta-Naltrexol |
LC/MS/MS |
0.1-140 ng/mL |
Human EDTA Plasma |
Current |
Naltrexol |
| 17-Desacetylnorgestimate |
LC/MS/MS |
45-3000 pg/mL |
Human EDTA Plasma |
Current |
Desacetylnorgestimate |
| 7-Aminoclonazepam |
LC/MS/MS |
200-100000 pg/mL |
Human EDTA Plasma |
Current |
Aminoclonazepam |
| 5-Aminosalicylic Acid (5-ASA) |
LC/MS/MS |
1-400 ng/mL |
Human EDTA Plasma |
Current |
Aminosalicylic Acid ( ASA) |
| 5-Aminosalicylic Acid (5-ASA); 5-Acetylaminosalicylic Acid (5-ACASA) |
HPLC/FL |
2-1000 ng/mL; 4-2000 ng/mL |
Human Sodium Heparin Plasma |
Current |
Aminosalicylic Acid ( ASA); Acetylaminosalicylic Acid ( ACASA) |
| 5-Aminosalicylic Acid (5-ASA); 5-Acetylaminosalicylic Acid (5-ACASA) |
HPLC/FLR |
2-600 ng/mL; 2-1200 ng/mL |
Human EDTA Plasma |
Current |
Aminosalicylic Acid ( ASA); Acetylaminosalicylic Acid ( ACASA) |
| 1,4-Diaminobutane (1,4DAB) |
LC/MS/MS |
2.5-50 ng/mL |
Human Serum |
Current |
Diaminobutane ( DAB) |
| 1-Alpha,25 Dihydroxyvitamin D2 |
LC/MS/MS |
2-50 pg/ ml |
Human EDTA Plasma |
Current |
Dihydroxyvitamin D |
| (+)-Fluvastatin; (-)-fluvastatin |
LC/MS/MS |
0.5-250 ng/mL |
Human Plasma |
Current |
Fluvastatin; fluvastatin |
| 3-Alpha Hydroxytibilone; 3-Beta Hydroxytibolone |
LC/MS/MS |
100-20000 pg/mL |
Human EDTA Plasma |
Current |
Hydroxytibilone; Hydroxytibolone |
| 2-Mercaptoethanesulfonic Acid (MESNA); 2,2-Dithiobis-Ethanesulfonic Acid (DIMESNA) |
LC/MS/MS |
10-8000 ng/mL; 25-20000 ng/mL |
Human Urine |
Current |
Mercaptoethanesulfonic Acid (MESNA); , Dithiobis Ethanesulfonic Acid (DIMESNA) |
| 2-Mercaptoethanesulfonic Acid (MESNA); 2,2-Dithiobis-Ethanesulfonic Acid (DIMESNA) |
LC/MS/MS |
40-10000 ng/mL; 500-250000 ng/mL |
Human Buffered Plasma |
Current |
Mercaptoethanesulfonic Acid (MESNA); , Dithiobis Ethanesulfonic Acid (DIMESNA) |
| 6-Mercaptopurine |
LC/MS/MS |
1-100 ng/mL |
Human EDTA Plasma |
Current |
Mercaptopurine |
| 17 Alpha-Methyltestosterone |
LC/MS/MS |
50-50000 pg/ml |
Human EDTA Plasma |
New |
Methyltestosterone |
| 5-Methyltetrahydrofolic Acid |
LC/MS/MS |
0.5-100 ng/mL |
Human Serum |
Current |
Methyltetrahydrofolic Acid |
| 2-Pyridylacetic Acid |
LC/MS/MS |
1-1000 ng/mL |
Human EDTA Plasma |
Current |
Pyridylacetic Acid |
| 2,3,4-Trihydroxybenzylhydrazine |
LC/MS/MS |
0.5-20 ng/mL |
Dog Plasma |
Current |
Trihydroxybenzylhydrazine |
| 2,3,4-Trihydroxybenzylhydrazine |
LC/MS/MS |
200-50000 pg/mL |
Human Plasma |
Current |
Trihydroxybenzylhydrazine |
| (-)-R-Lercanidipine; (-)-S-Lercanidipine |
LC/MS/MS |
25-10000 pg/mL; 50-15000 pg/mL |
Human Plasma |
Current |
Lercanidipine; Lercanidipine |
| Betamethasone |
LC/MS/MS |
0.5-100 ng/mL |
Human EDTA Plasma |
Current |
methasone |
| Betamethasone Acetate |
LC/MS/MS |
5-500 pg/mL |
Human EDTA Plasma |
Current |
methasone Acetate |
| Betamethasone Phosphate |
LC/MS/MS |
2.5 - 500 ng/mL |
Human EDTA Plasma |
Current |
methasone Phosphate |
| Betamethasone; Betamethasone Acetate |
LC/MS/MS |
0.5 - 50 ng/mL |
Human EDTA Plasma |
Current |
methasone; methasone Acetate |
| (-)-Nebivolol; (+)-Nebivolol |
LC/MS/MS |
10-2500 pg/mL |
Human Plasma |
Current |
Nebivolol; Nebivolol |
| (-)Paliperidone; (+)Paliperidone |
LC/MS/MS |
50-10000 pg/mL |
Human EDTA Plasma |
Current |
Paliperidone; Paliperidone |
| Acamprosate |
LC/MS/MS |
0.5-200 ng/mL |
Human EDTA Plasma |
Current |
Acamprosate |
| Aceclofenac |
LC/MS/MS |
15-15000 ng/mL |
Human EDTA Plasma |
Current |
Aceclofenac |
| Acetaminophen |
LC/MS/MS |
100-10000 ng/mL |
Human EDTA Plasma |
Current |
Acetaminophen |
| Acetyl Salicylic Acid |
LC/MS/MS |
2-300 ng/mL |
Human Buffered EDTA Plasma |
Current |
Acetyl Salicylic Acid |
| Acetyl Salicylic Acid; Salicylic Acid |
LC/MS/MS |
5-1500 ng/mL; 75-7500 ng/mL |
Human EDTA Plasma |
Current |
Acetyl Salicylic Acid; Salicylic Acid |
| Acyclovir |
LC/MS/MS |
0.5-40 ng/ml |
Human Urine |
Current |
Acyclovir |
| Acyclovir |
LC/MS/MS |
0.5-40000 pg/mL |
Human EDTA Plasma |
Current |
Acyclovir |
| Adefovir |
LC/MS/MS |
0.1-50 ng/mL |
Human EDTA Plasma |
Current |
Adefovir |
| Alendronic Acid |
LC/MS/MS |
1-1000 ng/mL |
Human Urine |
Current |
Alendronic Acid |
| Alendronic Acid |
LC/MS/MS |
50-50000 pg/mL |
Human Plasma |
Current |
Alendronic Acid |
| Alfuzosin |
HPLC/FLR |
0.2-100 ng/mL |
Human EDTA Plasma |
Current |
Alfuzosin |
| Aliskiren |
LC/MS/MS |
1-500 ng/mL |
Human EDTA Plasma |
Current |
Aliskiren |
| Allopurinol; Oxypurinol |
LC/MS/MS |
25-2000 ng/mL; 100-25000 ng/mL |
Human EDTA K3 Plasma |
Current |
Allopurinol; Oxypurinol |
| Allopurinol; Oxypurinol |
LC/MS/MS |
40-10000 ng/mL; 1-200 µg/mL |
Human Urine |
Current |
Allopurinol; Oxypurinol |
| Almotriptan |
LC/MS/MS |
0.2-100ng/mL |
Human EDTA Plasma |
Current |
Almotriptan |
| Alprazolam |
LC/MS/MS |
0.25-50 ng/mL |
Human EDTA Plasma |
Current |
Alprazolam |
| Alvimopan |
LC/MS/MS |
0.1-20 ng/mL |
Human EDTA Plasma |
Current |
Alvimopan |
| Alvimopan; ADL 08-0011 |
LC/MS/MS |
100-20000 pg/mL; 0.5-100 ng/mL |
Human EDTA Plasma |
Current |
Alvimopan; ADL |
| Amiodarone, Desethylamiodarone |
LC/MS/MS |
10-5000ng/ml; 0.5-250ng/ml |
Human Sodium EDTA Plasma |
Current |
Amiodarone, Desethylamiodarone |
| Amiodarone; Desethylamiodarone |
LC/MS/MS |
100-4000 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Amiodarone; Desethylamiodarone |
| Amiodarone; Desethylamiodarone |
LC/MS/MS |
10-25000 ng/mL; 0.5-200 ng/mL |
Human EDTA Plasma |
Current |
Amiodarone; Desethylamiodarone |
| Amisulpride |
LC/MS/MS |
1-500 ng/mL |
Human Plasma |
Current |
Amisulpride |
| Amlodipine |
LC/MS/MS |
20-10000 pg/mL |
Human Lithium Heparinized Plasma |
Current |
Amlodipine |
| Amlodipine |
LC/MS/MS |
50-10000 pg/mL |
Human EDTA Plasma |
Current |
Amlodipine |
| Amoxicillin |
LC/MS/MS |
40-20000 ng/mL |
Human EDTA Plasma |
Current |
Amoxicillin |
| Amphetamine (Chiral Method) |
LC/MS/MS |
0.2-50; 0.4-100 ng/mL |
Human EDTA Plasma |
Current |
Amphetamine (Chiral Method) |
| Anagrelide |
LC/MS/MS |
20-5000 pg/mL |
Human EDTA Plasma |
Current |
Anagrelide |
| Anastrozole |
LC/MS/MS |
100-20000 pg/ml |
Human Sodium Heparinized Pasma |
New |
Anastrozole |
| Anastrozole |
LC/MS/MS |
100-20000 pg/mL |
Human EDTA Plasma |
Current |
Anastrozole |
| Androstenedione |
GC/MS/MS |
25-2500 pg/mL |
Human Heparin Plasma |
Current |
Androstenedione |
| Androstenedione |
GC/MS/MS |
25-2500 pg/mL |
Human Serum |
Current |
Androstenedione |
| Apomorphine |
LC/MS/MS |
0.25-50 ng/mL |
Human Plasma |
Current |
Apomorphine |
| Aprepitant |
LC/MS/MS |
20-2000 ng/mL |
Human Plasma |
Current |
Aprepitant |
| Aripiprazole |
LC/MS/MS |
0.50-100 ng/mL |
Human EDTA Plasma |
Current |
Aripiprazole |
| Armodafinil |
LC/MS/MS |
20-10000 ng/mL |
Human EDTA Plasma |
Current |
Armodafinil |
| Atazanavir |
LC/MS/MS |
2-2000 ng/mL |
Human Plasma |
Current |
Atazanavir |
| Atenolol |
LC/MS |
5-1000 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Atenolol |
| Atomoxetine |
LC/MS/MS |
2-500 ng/mL |
Human Plasma |
Current |
Atomoxetine |
| Atorvastatin; O-Hydroxy-Atorvastatin; P-Hydroxy-Atorvastatin |
LC/MS/MS |
50-50000 pg/mL; 50-50000 pg/mL; 50-5000 pg/mL |
Human Plasma |
Current |
Atorvastatin; O Hydroxy Atorvastatin; P Hydroxy Atorvastatin |
| Atovaquone |
LC/MS/MS |
50-25000 ng/mL |
Human EDTA Plasma |
Current |
Atovaquone |
| Avonex |
ELISA |
5-200 pg/mL |
Human Serum |
Current |
Avonex |
| Azithromycin |
LC/MS/MS |
0.5-500 ng/mL |
Human EDTA K3 Plasma |
Current |
Azithromycin |
| Baclofen |
LC/MS/MS |
2-800 ng/mL |
Human EDTA Plasma |
Current |
Baclofen |
| Balsalazide |
LC/MS/MS |
1-500 ng/mL |
Human Plasma |
Current |
Balsalazide |
| Bazedoxifene |
LC/MS/MS |
20-20000 pg/mL |
Human EDTA Plasma |
Current |
Bazedoxifene |
| Benazepril; Benazeprilat |
LC/MS/MS |
3-1500 ng/mL |
Human EDTA Plasma |
Current |
Benazepril; Benazeprilat |
| Benserazide |
LC/MS/MS |
0.4-10 ng/mL |
Human EDTA Plasma |
Current |
Benserazide |
| Bicalutamide |
LC/MS |
25-1250 ng/mL |
Human EDTA Plasma |
Current |
Bicalutamide |
| Bismuth |
ICP/MS |
2-50 ng/ml |
Human EDTA Plasma |
Current |
Bismuth |
| Bisoprolol |
LC/MS/MS |
0.2-100 ng/mL |
Human EDTA Plasma |
Current |
Bisoprolol |
| Bivalirudin |
LC/MS/MS |
5-5000 ng/mL |
Human Sodium Citrate Plasma |
Current |
Bivalirudin |
| Bosentan |
LC/MS/MS |
2-2000 ng/ml |
Human EDTA Plasma |
Current |
Bosentan |
| Bromide |
ICP/MS |
0.5-50µg/mL |
Human Sodium Heparinized Plasma |
Current |
Bromide |
| Brompheniramine |
LC/MS/MS |
100-20000 pg/mL |
Human EDTA Plasma |
Current |
Brompheniramine |
| Budesonide |
LC/MS/MS |
2-2000 pg/mL |
Human EDTA Plasma |
Current |
Budenoside |
| Buflomedil |
HPLC/UV |
50-3000 ng/mL |
Human EDTA Plasma |
Current |
Buflomedil |
| Bupivacaine |
LC/MS/MS |
5-500 ng/mL |
Rat Plasma |
Current |
Bupivacaine |
| Bupivicaine |
LC/MS/MS |
100-5000 ng/mL |
Pig Plasma |
Current |
Bupivicaine |
| Buprenorphine;Norbuprenorphine |
LC/MS/MS |
20-4000 pg/mL;20-4000 pg/mL |
Human EDTA Plasma |
Current |
Buprenorphine;Norbuprenorphine |
| Bupropion; Hydroxybupropion |
LC/MS/MS |
0.2-200 ng/mL;0.6-600 ng/mL |
Human EDTA Plasma |
Current |
Bupropion; Hydroxybupropion |
| Bupropion; Hydroxybupropion; Erythrohydroxybupropion; Threohydroxybupropion |
LC/MS/MS |
1-200 ng/mL; 2-800ng/mL; 1-40 ng/mL; 1-200 ng/mL |
Human EDTA Plasma |
Current |
Bupropion; Hydroxybupropion; Erythrohydroxybupropion; Threohydroxybupropion |
| Butorphanol |
LC/MS/MS |
0.1-3.0 ng/mL |
Human Plasma |
Current |
Butorphanol |
| Cabergoline |
LC/MS/MS |
1-50 pg/mL |
Human EDTA Plasma |
Current |
Cabergoline |
| Cabergoline |
LC/MS/MS |
50-15000 pg/mL |
Rabbit EDTA Plasma |
Current |
Cabergoline |
| Calcitriol |
LC/MS/MS |
5-500 pg/mL |
Human EDTA Plasma |
Current |
Calcitriol |
| Calcitriol (1,25-Dihydrovitamin-D3) |
LC/MS/MS |
10-500 pg/mL |
Mini-Pig EDTA Plasam |
Current |
Calcitriol ( , Dihydrovitamin D ) |
| Candesartan |
LC/MS/MS |
0.5-250 ng/mL |
Human EDTA K2 Plasma |
Current |
Candesartan |
| Capecitabine |
LC/MS/MS |
10-10000 ng/mL |
Human EDTA K2 Plasma |
Current |
Capecitabine |
| Capecitabine; 5-DFCR |
LC/MS/MS |
10-5000 ng/mL |
Human EDTA Plasma |
Current |
Capecitabine; DFCR |
| Captopril (free) |
LC/MS/MS |
1-500 ng/mL |
Human EDTA Plasma |
Current |
Captopril (free) |
| Captopril (total) |
LC/MS/MS |
2-750 ng/mL |
Human EDTA Plasma |
Current |
Captopril (total) |
| Carbamazepine |
LC/MS/MS |
50-5000 ng/mL |
Human Plasma |
Current |
Carbamazepine |
| Carbamazepine; 10,11-Epoxide Carbamazepine |
LC/MS/MS |
50-5000 ng/mL; 10-250 ng/mL |
Human EDTA Plasma |
Current |
Carbamazepine; , Epoxide Carbamazepine |
| Carboplatin |
ICP/MS |
1-100 µg/mL |
Human EDTA Plasma |
Current |
Carboplatin |
| Carboplatin Free |
ICP/MS |
100-40000ng/mL |
Human EDTA Plasma |
Current |
Carboplatin Free |
| Carboplatin Total |
ICP/MS |
100-40000ng/mL |
Human EDTA Plasma |
Current |
Carboplatin Total |
| Carisoprodol; Meprobamate |
LC/MS/MS |
20-5000 ng/mL |
Human EDTA Plasma |
Current |
Carisoprodol; Meprobamate |
| Carvedilol; 4'-Hydroxyphenylcarvedilol |
LC/MS/MS |
0.25-200 ng/mL; 100-20000 ng/mL |
Human EDTA Plasma |
Current |
Carvedilol; ' Hydroxyphenylcarvedilol |
| Cefaclor |
LC/MS/MS |
50-25000 ng/mL |
Human EDTA Plasma |
Current |
Cefaclor |
| Cefadroxil |
LC/MS/MS |
200-40000 ng/mL |
Human EDTA Plasma |
Current |
Cefadroxil |
| Cefatrizine |
HPLC/FLR |
100-1000 ng/mL |
Human EDTA K3 Plasma |
Current |
Cefatrizine |
| Cefdinir |
LC/MS/MS |
25-5000 ng/mL |
Human EDTA K3 Plasma |
Current |
Cefdinir |
| Cefixime |
LC/MS/MS |
20-10000 ng/mL |
Human EDTA Plasma |
Current |
Cefixime |
| Cefpodoxime |
LC/MS/MS |
20-5000 ng/mL |
Human EDTA Plasma |
Current |
Cefpodoxime |
| Cefprozil (Z)-Isomer and Cefprozil (E)-Isomer |
LC/MS/MS |
100-10000 ng/mL (Z); 11 - 1110 ng/mL (E) |
Human EDTA Plasma |
Current |
Cefprozil (Z) Isomer and Cefprozil (E) Isomer |
| Cefuroxime |
HPLC/UV |
50-25000 ng/mL |
Human EDTA Plasma |
Current |
Cefuroxime |
| Celecoxib |
LC/MS/MS |
10-2000 ng/mL |
Human EDTA Plasma |
Current |
Celecoxib |
| Celecoxib |
LC/MS/MS |
10-2000ng/ml |
Human Plasma |
Current |
Celecoxib |
| Cephalexin |
LC/MS/MS |
50-25000 ng/mL |
Human EDTA Plasma |
Current |
Cephalexin |
| Cetirizine |
HPLC/UV |
5-400 ng/mL |
Human Plasma |
Current |
Cetirizine |
| Chlormadinone Acetate; 3-Hydroxy Chlormadinone Acetate |
LC/MS/MS |
50-5000 pg/mL |
Human EDTA Plasma |
Current |
Chlormadinone Acetate; Hydroxy Chlormadinone Acetate |
| Chlorpheniramine |
LC/MS/MS |
0.2-100 ng/mL |
Human EDTA Plasma |
Current |
Chlorpheniramine |
| Cholecalciferol |
LC/MS/MS |
0.5-50 ng/mL |
Human EDTA Plasma |
Current |
Cholecalciferol |
| Ciclopirox |
LC/MS/MS |
1-100 ng/mL |
Rat Plasma |
Current |
Ciclopirox |
| Ciclopirox |
LC/MS/MS |
1-500 ng/mL |
Human Urine |
Current |
Ciclopirox |
| Ciclopirox |
LC/MS/MS |
50-5000 pg/mL |
Human EDTA Plasma |
Current |
Ciclopirox |
| Cilostazol |
LC/MS/MS |
5-1500 ng/mL |
Human EDTA Plasma |
Current |
Cilostazol |
| Cilostazol; OPC-13213;OPC-13015 |
LC/MS/MS |
5-1500 ng/mL; 1-100ng/mL; 2-200 ng/mL |
Human EDTA Plasma |
Current |
Cilostazol; OPC ;OPC |
| Cinacalcet |
LC/MS/MS |
100-50000 pg/mL |
Human Plasma |
Current |
Cinacalcet |
| Ciprofibrate |
LC/MS |
0.25-50 µg/mL |
Human Plasma |
Current |
Ciprofibrate |
| Ciprofloxacin |
HPLC/FL |
20-5000 ng/mL |
Human Plasma |
Current |
Ciprofloxacin |
| Cisapride; Norcisapride |
LC/MS/MS |
0.5-200 ng/mL |
Human EDTA Plasma |
Current |
Cisapride; Norcisapride |
| Cisplatin |
ICP/MS |
0.2-20 µg/mL |
Human EDTA Plasma |
Current |
Cisplatin |
| Cisplatin Free |
ICP/MS |
40-8000 ng/mL |
Human EDTA Plasma |
Current |
Cisplatin Free |
| Citalopram |
LC/MS/MS |
0.2-100 ng/mL |
Human EDTA Plasma |
Current |
Citalopram |
| Clarithromycin |
LC/MS/MS |
20-5000 ng/mL |
Human EDTA Plasma |
Current |
Clarithromycin |
| Clarithromycin; 14-hydroxy Clarithromycin |
LC/MS/MS |
2.5-2500 ng/mL; 2-2000 ng/mL |
Human EDTA Plasma |
Current |
Clarithromycin; hydroxy Clarithromycin |
| Clavulanic Acid |
LC/MS/MS |
40-4000 ng/mL |
Human EDTA Plasma |
Current |
Clavulanic Acid |
| Clindamycin |
LC/MS/MS |
10-5000 ng/mL |
Human EDTA Plasma |
Current |
Clindamycin |
| Clomiphene Cis (Z) and Trans (E) Isomers |
LC/MS/MS |
100-20000 pg/mL; 50-10000 pg/mL |
Human EDTA Plasma |
Current |
Clomiphene Cis (Z) and Trans (E) Isomers |
| Clonazepam |
LC/MS/MS |
100-50000 ng/mL |
Human EDTA Plasma |
Current |
Clonazepam |
| Clonidine |
LC/MS/MS |
10-10000 pg/mL |
Goat EDTA Plasam |
Current |
Clonidine |
| Clonidine |
LC/MS/MS |
10-400 pg/mL |
Human EDTA Plasma |
Current |
Clonidine |
| Clonidine |
LC/MS/MS |
20-20000 pg/mL |
Rat EDTA Plasma |
Current |
Clonidine |
| Clopidogrel |
LC/MS/MS |
5-2500 pg/mL |
Human Plasma |
Current |
Clopidogrel |
| Clopidogrel Carboxylic Acid |
LC/MS/MS |
15-7500 ng/mL |
Rat EDTA Plasma |
Current |
Clopidogrel Carboxylic Acid |
| Clopidogrel Carboxylic Acid |
LC/MS/MS |
4-4000 ng/mL |
Human EDTA Plasma |
Current |
Clopidogrel Carboxylic Acid |
| Cloxacillin |
LC/MS/MS |
50-20000 ng/ml |
Human EDTA Plasma |
Current |
Cloxacillin |
| Clozapine; N-Desmethylclozapine |
LC/MS/MS |
2-1000 ng/mL; 1-500 ng/mL |
Human EDTA Plasma |
Current |
Clozapine; N Desmethylclozapine |
| Cocaine; Benzoylecgonine |
LC/MS/MS |
5-500 ng/mL; 10-1000 ng/mL |
Human EDTA Plasma |
Current |
Cocaine; Benzoylecgonine |
| Codeine |
LC/MS/MS |
0.5-100 ng/mL |
Human EDTA K3 Plasma |
Current |
Codeine |
| Codeine, Norcodeine; Codeine-6-Glucuronide |
LC/MS/MS |
0.5-100 ng/mL; 2-400 ng/mL; 2-400 ng/mL |
Human EDTA K3 Plasma |
Current |
Codeine, Norcodeine; Codeine Glucuronide |
| Colchicine |
LC/MS/MS |
40-10000 pg/mL |
Human EDTA K3 Plasma |
Current |
Colchicine |
| Cortisol |
LC/MS/MS |
0.2-50 ng/mL |
Human EDTA Plasma |
Current |
Cortisol |
| Cortisol |
RIA |
5-200 ng/mL |
Human Serum |
Current |
Cortisol |
| Cyclosporin A |
LC/MS/MS |
2-1000 ng/mL |
Human EDTA Whole Blood |
Current |
Cyclosporin A |
| Cyproterone Acetate |
LC/MS/MS |
100-50000 pg/mL |
Human EDTA Plasma |
Current |
Cyproterone Acetate |
| Cytarabine; ARA-U |
LC/MS/MS |
1-100 µg/mL; 100-10000 ng/mL |
Rat EDTA Plasma |
Current |
Cytarabine; ARA U |
| D-Threo-Methylphenidate |
LC/MS/MS |
100-5000 pg/mL |
Human EDTA Plasma |
Current |
D Threo Methylphenidate |
| D-Threo-Methylphenidate; L-Threo-Methylphenidate |
LC/MS/MS |
100-5000 pg/mL; 2-200 pg/mL |
Human EDTA Plasma |
Current |
D Threo Methylphenidate; L Threo Methylphenidate |
| Dabigatran |
LC/MS/MS |
1-400 ng/mL |
Human EDTA Plasma |
Current |
Dabigatran |
| Dapsone |
LC/MS/MS |
5-4000 ng/mL |
Human Sodium Fluoride/Potassium Oxalate Plasma |
Current |
Dapsone |
| Darifenacin |
LC/MS/MS |
20-10000 pg/mL |
Human Plasma |
Current |
Darifenacin |
| Dasatinib |
LC/MS/MS |
0.25-250 ng/mL |
Human EDTA Plasma |
Current |
Dasatinib |
| Daunorubicin; Daunorubicinol |
LC/MS/MS |
2-800 ng/mL; 2-200 ng/mL |
Rat EDTA Plasma |
Current |
Daunorubicin; Daunorubicinol |
| Deferasirox |
LC/MS/MS |
50-25000 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Deferasirox |
| Dehydroepiandrosterone (DHEA) |
RIA |
0.5-20 ng/mL |
Human Serum |
Current |
Dehydroepiandrosterone (DHEA) |
| Dehydroepiandrosterone Sulfate (DHEAS) |
RIA |
100-5000 ng/mL |
Human Serum |
Current |
Dehydroepiandrosterone Sulfate (DHEAS) |
| Descarboethoxy Loratadine; 3-Hydroxy Desloratadine |
LC/MS/MS |
25-5000 pg/mL; 25-2500 pg/mL |
Human EDTA Plasma |
Current |
Descarboethoxy Loratadine; Hydroxy Desloratadine |
| Desipramine |
GC/ECNCI/MS/MS |
0.5-100 ng/mL |
Human Heparin Plasma |
Current |
Desipramine |
| Desipramine; 2-Hydroxydesipramine |
LC/MS/MS |
0.25-150 ng/mL |
Human EDTA K3 Plasma |
Current |
Desipramine; Hydroxydesipramine |
| Desipramine; 2-Hydroxydesipramine |
LC/MS/MS |
0.5-150 ng/mL; 0.25-75 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Desipramine; Hydroxydesipramine |
| Dexamethasone |
LC/MS/MS |
100-50000 pg/mL |
Human Plasma |
Current |
Dexamethasone |
| Dexlansoprazole |
LC/MS/MS |
2-2000 ng/ml |
Human EDTA Plasma |
New |
Dexlansoprazole |
| Dexmedetomidine |
LC/MS/MS |
30-3000 pg/ml |
Human Lithium Heparinized Plasma |
Current |
Dexmedetomidine |
| Dextromethorphan/Total Dextrorphan |
LC/MS/MS |
0.0200 – 20.0 ng/mL; 0.400 – 400 ng/mL |
Human Sodium Heparin Plasma |
Current |
Dextromethorphan/Total Dextrorphan |
| Dextromethorphan; Dextrorphan |
LC/MS/MS |
4-2000 ng/mL; 40-20000 ng/mL |
Human Urine |
Current |
Dextromethorphan; Dextrorphan |
| Dextromethorphan; Dextrorphan |
LC/MS/MS |
50-25000 pg/mL; 25-12500 pg/mL |
Human Plasma |
Current |
Dextromethorphan; Dextrorphan |
| Diazepam |
LC/MS/MS |
4-400 ng/mL |
Human Plasma |
Current |
Diazepam |
| Diazoxide |
LC/MS/MS |
1-1000 ng/mL |
Human EDTA Plasma |
Current |
Diazoxide |
| Diclofenac |
LC/MS/MS |
50-20000 pg/mL |
Human EDTA Plasma |
Current |
Diclofenac |
| Didanosine |
LC/MS/MS |
25-2500 ng/mL |
Human EDTA Plasma |
Current |
Didanosine |
| Dienogest |
LC/MS/MS |
1-160 ng/mL |
Human EDTA Plasma |
Current |
Dienogest |
| Diflunisal |
LC/MS/MS |
0.4-200um/mL |
Human EDTA Plasma |
Current |
Diflunisal |
| Digoxin |
LC/MS/MS |
100-10000 pg/mL |
Human Urine |
Current |
Digoxin |
| Digoxin |
LC/MS/MS |
50-5000 pg/mL |
Human Sodium Heparinized Plasma |
Current |
Digoxin |
| Digoxin |
RIA |
100-5000 pg/mL |
Human Serum |
Current |
Digoxin |
| Dihydroergotamine |
LC/MS/MS |
50-5000 pg/mL |
Human Plasma |
Current |
Dihydroergotamine |
| Diltiazem, N-Desmethyldiltiazem; Deacetyldiltiazem |
LC/MS/MS |
2-400 ng/mL; 0.5-100 ng/mL; 0.5-100 ng/mL |
Human EDTA Plasma |
Current |
Diltiazem, N Desmethyldiltiazem; Deacetyldiltiazem |
| Dipyridamole |
LC/MS/MS |
20-4000 ng/mL |
Human EDTA Plasma |
Current |
Dipyridamole |
| Docetaxel |
LC/MS/MS |
5-5000 ng/mL |
Human EDTA Plasma |
Current |
Docetaxel |
| Docetaxel Free |
LC/MS/MS |
0.8-400 ng/mL |
Human EDTA Plasma |
Current |
Docetaxel Free |
| Docetaxel Total (Lower LLOQ) |
LC/MS/MS |
5-5000 ng/mL |
Human EDTA Plasma |
Current |
Docetaxel Total (Lower LLOQ) |
| Docosahexaenoic Acid (DHA) |
LC/MS/MS |
10-1000 ug/ml |
Human EDTA Plasma |
New |
Docosahexaenoic Acid (DHA) |
| Docosahexaenoic Acid (DHA) Free |
LC/MS/MS |
10-2500 ug/ml |
Human EDTA Plasma |
New |
Docosahexaenoic Acid (DHA) Free |
| Dodecyl Maltoside |
LC/MS/MS |
0.5-2500 ng/ml |
Human EDTA Plasma |
Current |
Dodecyl Maltoside |
| Domperidone |
LC/MS/MS |
0.1-40 ng/mL |
Human EDTA Plasma |
Current |
Domperidone |
| Donepezil |
LC/MS/MS |
100-25000 pg/mL |
Human EDTA Plasma |
Current |
Donepezil |
| Doxercalciferol |
LC/MS/MS |
5-100 pg/mL |
Human EDTA K3 Plasma |
Current |
Doxercalciferol |
| Doxycycline |
LC/MS |
4-400 ng/mL |
Human EDTA Plasma |
Current |
Doxycycline |
| Doxylamine |
LC/MS/MS |
0.5-250 ng/ml |
Human EDTA K2 Plasma |
Current |
Doxylamine |
| Drospirenone |
LC/MS/MS |
100-40000 pg/mL |
Human EDTA Plasma |
Current |
Drospirenone |
| Duloxetine |
LC/MS/MS |
0.5-100 ng/mL |
Human Plasma |
Current |
Duloxetine |
| Dutasteride |
LC/MS/MS |
50-5000 pg/mL |
Human EDTA Plasma |
Current |
Dutasteride |
| Efavirenz |
LC/MS/MS |
20-4000 ng/mL |
Human Plasma |
Current |
Efavirenz |
| Eicosapentaenoic Acid (EPA) |
LC/MS/MS |
2-200 µg/mL |
Human EDTA Plasma |
Current |
Eicosapentaenoic Acid (EPA) |
| Eicosapentaenoic Acid (EPA) Free |
LC/MS/MS |
25-800 ng/ml |
Human EDTA Plasma |
New |
Eicosapentaenoic Acid (EPA) Free |
| Eletriptan; Desmethyl Eletriptan |
LC/MS/MS |
500-250000 pg/mL |
Human EDTA Plasma |
Current |
Eletriptan; Desmethyl Eletriptan |
| Emtricitabine |
LC/MS/MS |
5-5000 ng/mL |
Human EDTA Plasma |
Current |
Emtricitabine |
| Enalapril; Enalaprilat |
LC/MS/MS |
0.5-200 ng/mL |
Human EDTA Plasma |
Current |
Enalapril; Enalaprilat |
| Eniluracil |
LC/MS/MS |
1-250 ng/mL |
Human Plasma |
Current |
Eniluracil |
| Entacapone |
LC/MS/MS |
10-2000 ng/mL |
Human EDTA Plasma |
Current |
Entacapone |
| Entecavir |
LC/MS/MS |
50-10000 pg/mL |
Human EDTA Plasma |
Current |
Entecavir |
| Ephedrine |
LC/MS/MS |
1-100 ng/mL |
Human EDTA Plasma |
Current |
Ephedrine |
| Epirubicin |
LC/MS/MS |
5-1000 ng/mL |
Rabbit Plasma |
Current |
Epirubicin |
| Epirubicin; Epirubicinol |
LC/MS/MS |
5-1000 ng/mL; 2-200 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Epirubicin; Epirubicinol |
| Eplerenone |
LC/MS/MS |
10-2500 ng/mL |
Human EDTA Plasma |
Current |
Eplerenone |
| Ergocalciferol |
LC/MS/MS |
100-100000 pg/ml |
Human EDTA Plasma |
New |
Ergocalciferol |
| Erlotinib |
LC/MS/MS |
10-5000 ng/mL |
Human Plasma |
Current |
Erlotinib |
| Erythromycin |
LC/MS/MS |
20-1000 ng/mL |
Human EDTA Plasma |
Current |
Erythromycin |
| Erythromycin |
LC/MS/MS |
50-20000 ng/mL |
Human Urine |
Current |
Erythromycin |
| Erythromycin; Erythromycin Ethylsuccinate |
LC/MS/MS |
20-2000 ng/mL |
Human EDTA Plasma |
Current |
Erythromycin; Erythromycin Ethylsuccinate |
| Erythropoietin |
ELISA |
10-4000 mIU/mL |
Human Serum |
Current |
Erythropoietin |
| Erythropoietin (Recombinant Human) |
ELISA |
10-500ml/ml |
Human Serum |
Current |
Erythropoietin (Recombinant Human) |
| Escitalopram |
LC/MS/MS |
100-15000 pg/mL |
Human Plasma |
Current |
Escitalopram |
| Esomeprazole |
LC/MS/MS |
1.5-750 ng/mL |
Human EDTA Plasma |
Current |
Esomeprazole |
| Estradiol |
LC/MS/MS |
2.5-100 pg/mL |
Human EDTA Plasma |
Current |
Estradiol |
| Estradiol; 17 Beta |
GC/MS/MS |
0.625-80 pg/mL |
Human Heparin Plasma |
Current |
Estradiol; |
| Estradiol; 17 Beta |
GC/MS/MS |
0.625-80 pg/mL |
Human Serum |
Current |
Estradiol; |
| Estrone |
GC/MS/MS |
1.56-200 pg/mL |
Human Heparin Plasma |
Current |
Estrone |
| Estrone |
GC/MS/MS |
1.56-200 pg/mL |
Human Serum |
Current |
Estrone |
| Estrone (Total) |
LC/MS/MS |
25-25000 pg/mL |
Human EDTA Plasma |
Current |
Estrone (Total) |
| Estrone Conjugates |
GC/MS/MS |
3.13-800 pg/mL |
Human Heparin Plasma |
Current |
Estrone Conjugates |
| Estrone Conjugates |
GC/MS/MS |
3.13-800 pg/mL |
Human Serum |
Current |
Estrone Conjugates |
| Estrone; Estradiol |
LC/MS/MS |
5-1000 pg/mL; 2.5-500 pg/mL |
Human Plasma |
Current |
Estrone; Estradiol |
| Eszopiclone |
LC/MS/MS |
0.25-50 ng/mL |
Human Plasma |
Current |
Eszopiclone |
| Ethanol |
GC/MS |
5-500 µg/mL |
Human Whole Blood |
Current |
Ethanol |
| Ethinyl Estradiol |
LC/MS/MS |
1-250 pg/mL |
Human Plasma |
Current |
Ethinyl Estradiol |
| Ethinyl Estradiol; Gestodene |
LC/MS/MS |
2-250 pg/mL; 50-25000 pg/mL |
Human EDTA Plasma |
Current |
Ethinyl Estradiol; Gestodene |
| Ethinyl Estradiol; Nestorone |
GC/MS/MS |
10-1000 pg/mL; 50-5000 pg/mL |
Human Serum |
Current |
Ethinyl Estradiol; Nestorone |
| Ethinyl Estradiol; Norethindrone |
LC/MS/MS |
1-200 pg/mL; 100-40000 pg/mL |
Human EDTA Plasma |
Current |
Ethinyl Estradiol; Norethindrone |
| Etidronic Acid |
GC/MS |
2-800 ng/mL |
Human EDTA Plasma |
Current |
Etidronic Acid |
| Etodolac |
HPLC/UV |
100-40000 ng/mL |
Human EDTA Plasma |
Current |
Etodolac |
| Etonogestrel (3-Ketodesogestrel) |
LC/MS/MS |
10-2000 pg/mL |
Human EDTA Plasma |
Current |
Etonogestrel ( Ketodesogestrel) |
| Etoposide |
LC/MS/MS |
20-5000 ng/mL |
Human EDTA Plasma |
Current |
Etoposide |
| Etoposide |
LC/MS/MS |
20-5000 ng/mL |
Human Serum |
Current |
Etoposide |
| Everolimus |
LC/MS/MS |
0.2-100 ng/mL |
Human EDTA Whole Blood |
Current |
Everolimus |
| Exemestane |
LC/MS/MS |
100-20000 pg/mL |
Human Plasma |
Current |
Exemestane |
| Ezetimibe (Total) |
LC/MS/MS |
200-75000 pg/mL |
Human EDTA Plasma |
Current |
Ezetimibe (Total) |
| Ezetimibe (Unconjugated) |
LC/MS/MS |
40-20000 pg/mL |
Human EDTA Plasma |
Current |
Ezetimibe (Unconjugated) |
| Famotidine |
LC/MS/MS |
0.5-200 ng/mL |
Human EDTA Plasma |
Current |
Famotidine |
| Febuxostat |
LC/MS/MS |
10-10000 ng/mL |
Human EDTA Plasma |
Current |
Febuxostat |
| Felbinac |
HPLC/FLR |
5-2000 ng/mL |
Human Serum |
Current |
Felbinac |
| Felodipine |
LC/MS/MS |
20-10000 pg/mL |
Human EDTA Plasma |
Current |
Felodipine |
| Fenofibric Acid |
LC/MS/MS |
50-25000 ng/mL |
Human EDTA Plasma |
Current |
Fenofibric Acid |
| Fentanyl |
LC/MS/MS |
10-5000 pg/mL |
Human EDTA Plasma |
Current |
Fentanyl |
| Fesoterodine; 5-Hydroxymethyl Tolteronidine |
LC/MS/MS |
2-200 µg/mL; 50-1000 µg/mL |
Human EDTA Plasma |
Current |
Fesoterodine; Hydroxymethyl Tolteronidine |
| Fexofenadine |
LC/MS/MS |
0.5-500 ng/mL |
Human EDTA Plasma |
Current |
Fexofenadine |
| Fexofenadine |
LC/MS/MS |
10-5000 ng/mL |
Human Urine |
Current |
Fexofenadine |
| Finasteride |
LC/MS/MS |
0.5-200 ng/mL |
Human EDTA Plasma |
Current |
Finasteride |
| Flecainide |
HPLC/FLR |
2-500 ng/mL |
Human EDTA Plasma |
Current |
Flecainide |
| Flosequinan; Sulfone Metabolite |
LC/MS/MS |
10-800 ng/mL |
Human Heparinized Plasma |
Current |
Flosequinan; Sulfone Metabolite |
| Fluconazole |
LC/MS/MS |
37.5-15000 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Fluconazole |
| Fluorouracil |
LC/MS/MS |
5-2500 ng/mL |
Human EDTA Plasma |
Current |
Fluorouracil |
| Fluoxetine; Norfluoxetine |
LC/MS |
0.5-60 ng/mL |
Human Lithium Heparinized Plasma |
Current |
Fluoxetine; Norfluoxetine |
| Fluoxetine; Norfluoxetine: Ondansetron |
LC/MS/MS |
2-1000 ng/ml; 5-2500 ng/ml; 2.5-1000 ng/ml |
Rat Plasma |
Current |
Fluoxetine; Norfluoxetine: Ondansetron |
| Fluticasone Propionate |
LC/MS/MS |
1-500 pg/ml |
Human EDTA Plasma |
New |
Fluticasone Propionate |
| Fluvastatin |
LC/MS/MS |
0.5-500 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Fluvastatin |
| Fluvoxamine |
LC/MS/MS |
0.5-200 ng/mL |
Human EDTA Plasma |
Current |
Fluvoxamine |
| Formoterol |
LC/MS/MS |
250-125000 fg/mL |
Human Sodium Fluoride/Potassium Oxalate Plasma |
Current |
Formoterol |
| Fosinopril |
LC/MS/MS |
100-10000 pg/mL |
Human EDTA Plasma |
Current |
Fosinopril |
| Fosinoprilat |
LC/MS/MS |
1-500 ng/mL |
Human EDTA K3 Plasma |
Current |
Fosinoprilat |
| FSH (Follicle Stimulating Hormone) |
RIA |
2-100 mIU/mL |
Human Serum |
Current |
FSH (Follicle Stimulating Hormone) |
| Furosemide |
LC/MS/MS |
50-4000 ng/mL |
Human EDTA K2 Plasma |
Current |
Furosemide |
| Furosemide |
LC/MS/MS |
5-1000 ng/mL |
Human Urine |
Current |
Furosemide |
| Gabapentin |
LC/MS/MS |
100-50000 ng/mL |
Human Cerebrospinal Fluid (CSF) |
Current |
Gabapentin |
| Gabapentin |
LC/MS/MS |
25-10000 ng/mL |
Human Plasma |
Current |
Gabapentin |
| Gabapentin Lactam |
LC/MS/MS |
1.5-300 ng/mL |
Human EDTA Plasma |
Current |
Gabapentin Lactam |
| Galanthamine |
LC/MS/MS |
0.5-100 ng/mL |
Human EDTA Plasma |
Current |
Galanthamine |
| Gemcitabine |
LC/MS/MS |
100-50000 ng/mL |
Human EDTA Plasma |
Current |
Gemcitabine |
| Gemcitabine; 2,2-Difluror-2-Deoxyuridine |
LC/MS/MS |
100-50000 ng/ml; 100-100000 ng/ml |
Human EDTA Plasma |
New |
Gemcitabine; , Difluror Deoxyuridine |
| Gemfibrozil |
LC/MS/MS |
100- 40000 ng/mL |
Human EDTA Plasma |
Current |
Gemfibrozil |
| Gemfibrozil (Total) |
LC/MS/MS |
32.5-6500 ng/ml |
Human EDTA Plasma |
New |
Gemfibrozil (Total) |
| Gemfibrozil; Gemfibrozil Glucuronide |
LC/MS/MS |
50-50000 ng/ml; 15-15000 ng/ml |
Human EDTA Plasma |
New |
Gemfibrozil; Gemfibrozil Glucuronide |
| Gestodene |
LC/MS/MS |
50-12500 pg/mL |
Human EDTA Plasma |
Current |
Gestodene |
| Gestodene |
LC/MS/MS |
50-25000 pg/mL |
Human Lithium Heparinized Plasma |
Current |
Gestodene |
| Gestodene/Ethinyl Estradiol |
LC/MS/MS |
2.50-250 pg/mL |
Human Serum |
Current |
Gestodene/Ethinyl Estradiol |
| Gliclazide |
LC/MS/MS |
20-4000 ng/mL |
Human EDTA Plasma |
Current |
Gliclazide |
| Glimepiride |
LC/MS/MS |
1-250 ng/mL |
Human EDTA K3 Plasma |
Current |
Glimepiride |
| Glimepiride |
LC/MS/MS |
1-500 ng/mL |
Human EDTA Plasma |
Current |
Glimepiride |
| Glipizide |
LC/MS/MS |
1-500 ng/mL |
Human EDTA Plasma |
Current |
Glipizide |
| Glucose |
ELISA |
12-300 mg/dL |
Human Serum |
Current |
Glucose |
| Glyburide |
LC/MS/MS |
1-300 ng/mL |
Human Heparin Plasma |
Current |
Glyburide |
| Glyburide |
LC/MS/MS |
2-300 ng/mL |
Human EDTA Plasma |
Current |
Glyburide |
| Granisetron |
LC/MS/MS |
0.3-30 ng/mL |
Human EDTA Plasma |
Current |
Granisetron |
| Guaifenesin |
LC/MS/MS |
10-5000 ng/mL |
Human EDTA Plasma |
Current |
Guaifenesin |
| Halobetasol Propionate |
LC/MS/MS |
50-20000 pg/mL |
Rat EDTA Plasma |
Current |
Halo sol Propionate |
| Haloperidol |
LC/MS/MS |
0.1-5.0 ng/mL |
Human Plasma |
Current |
Haloperidol |
| Human Growth Hormone(hGH) |
ELISA |
0.3-45 ng/mL |
Human Serum |
Current |
Human Growth Hormone(hGH) |
| Hydrochlorothiazide |
LC/MS/MS |
1-250 ng/mL |
Human EDTA Plasma |
Current |
Hydrochlorothiazide |
| Hydrocodone |
LC/MS/MS |
150-30000 pg/mL |
Human Plasma |
Current |
Hydrocodone |
| Hydromorphone |
LC/MS/MS |
5-2500 pg/mL |
Human EDTA Plasma |
Current |
Hydromorphone |
| Hydroxy Acid Lovastatin |
LC/MS/MS |
200-50000 pg/mL |
Human EDTA Plasma |
Current |
Hydroxy Acid Lovastatin |
| Hydroxybupropion |
LC/MS/MS |
1-400 ng/mL |
Human EDTA Plasma |
Current |
Hydroxybupropion |
| Hyoscine N-Butyl Bromide |
LC/MS/MS |
10-5000 pg/mL |
Human EDTA Plasma |
Current |
Hyoscine N Butyl Bromide |
| Ibandronic Acid |
LC/MS/MS |
20-2000 pg/mL |
Human Plasma |
Current |
Ibandronic Acid |
| Ibuprofen |
LC/MS/MS |
10-5000 ng/mL |
Human EDTA Plasma |
Current |
Ibuprofen |
| Imatinib; Desmethyl Imatinib |
LC/MS/MS |
20-4000 ng/mL |
Human Whole Blood |
Current |
Imatinib; Desmethyl Imatinib |
| Imipramine; Desipramine |
LC/MS/MS |
200-100000 pg/mL; 100-50000 pg/mL |
Human Plasma |
Current |
Imipramine; Desipramine |
| Indapamide |
LC/MS/MS |
0.25-125 ng/mL |
Human Whole Blood |
Current |
Indapamide |
| Insulin-Like Growth Factor 1 (IGF-1) |
ELISA |
31.25-1000 ng/mL |
Human Serum |
Current |
Insulin Like Growth Factor (IGF ) |
| Interferon Alpha2B |
ELISA |
20-2500 pg/mL |
Human Serum |
Current |
Interferon Alpha B |
| Irbesartan |
LC/MS/MS |
20-8000 ng/mL |
Human EDTA Plasma |
Current |
Irbesartan |
| Isosorbide 5-Mononitrate |
LC/MS/MS |
5-1250 ng/mL |
Human EDTA Plasma |
Current |
Isosorbide Mononitrate |
| Isotretinoin |
LC/MS/MS |
1-600 ng/mL |
Human EDTA Plasma |
Current |
Isotretinoin |
| Isotretinoin; 4-Oxo-Isotretinoin |
LC/MS/MS |
1-800 ng/mL |
Human EDTA Plasma |
Current |
Isotretinoin; Oxo Isotretinoin |
| Isradipine |
LC/MS/MS |
20-10000 pg/mL |
Human EDTA Plasma |
Current |
Isradipine |
| Itraconazole |
HPLC/FLR |
2-500 ng/mL |
Human EDTA Plasma |
Current |
Itraconazole |
| Ketoconazole |
LC/MS/MS |
20-10000 ng/mL |
Human Heparinized Plasma |
Current |
Ketoconazole |
| Ketoconazole |
LC/MS/MS |
5-1000 ng/mL |
Human Heparinized Plasma |
Current |
Ketoconazole |
| Ketoprofen |
LC/MS/MS |
0.1-15 µg/mL |
Human Heparin Plasma |
Current |
Ketoprofen |
| Ketoprofen |
LC/MS/MS |
0.1-15 µg/mL |
Human Urine |
Current |
Ketoprofen |
| Ketoprofen |
LC/MS/MS |
2-400 ng/mL |
Human EDTA K2 Plasma |
Current |
Ketoprofen |
| L-Citrulline |
LC/MS/MS |
150-10000 ng/mL |
Human EDTA Plasma |
Current |
L Citrulline |
| L-Citrulline |
LC/MS/MS |
500 - 20000 ng/mL |
Rat EDTA Plasma |
Current |
L Citrulline |
| Lacidipine |
LC/MS/MS |
20-5000 pg/mL |
Human EDTA Plasma |
Current |
Lacidipine |
| Lacosamide; Desmethyl Lacosamide |
LC/MS/MS |
50-20000 pg/mL; 5-2000 ng/ml |
Human EDTA Plasma |
New |
Lacosamide; Desmethyl Lacosamide |
| Lamivudine |
LC/MS/MS |
10-5000 ng/mL |
Human EDTA Plasma |
Current |
Lamivudine |
| Lamotrigine |
LC/MS |
50-10000 ng/mL |
Human EDTA Plasma |
Current |
Lamotrigine |
| Lansoprazole |
LC/MS/MS |
2-2000 ng/mL |
Human EDTA Plasma |
Current |
Lansoprazole |
| Lapatinib |
LC/MS/MS |
100-10000 ng/mL |
Human EDTA Plasma |
Current |
Lapatinib |
| Leflunomide |
LC/MS/MS |
20-4000 pg/ml |
Human EDTA Plasma |
Current |
Leflunomide |
| Lercanidipine |
LC/MS/MS |
25-10000 pg/mL |
Human EDTA Plasma |
Current |
Lercanidipine |
| Letrozole |
LC/MS/MS |
0.50-200 ng/mL |
Human EDTA K3 Plasma |
Current |
Letrozole |
| Leukotriene B4 |
LC/MS/MS |
0.5-250 ng/mL |
Rat EDTA Plasma |
Current |
Leukotriene B |
| Leukotriene B4 |
LC/MS/MS |
25-12500 pg/mL |
Human EDTA Plasma |
Current |
Leukotriene B |
| Leukotriene B4 |
LC/MS/MS |
25-12500 pg/mL |
Human Urine |
Current |
Leukotriene B |
| Leuprolide |
LC/MS/MS |
0.1-100 ng/mL |
Human EDTA Plasma |
Current |
Leuprolide |
| Levetiracetam |
LC/MS/MS |
100-40000 ng/mL |
Human EDTA Plasma |
Current |
Levetiracetam |
| Levodopa |
LC/MS/MS |
10-6000 ng/mL |
Human EDTA Plasma |
Current |
Levodopa |
| Levofloxacin |
HPLC/FLR |
100-50000 ng/mL |
Human Serum/Sputum Homogenate |
Current |
Levofloxacin |
| Levofloxacin |
HPLC/FLR |
200-100000 ng/mL |
Human Urine |
Current |
Levofloxacin |
| Levomethadone; Dextromethadone |
LC/MS/MS |
0.5-100 ng/mL |
Human Lithium Heparinized Plasma |
Current |
Levomethadone; Dextromethadone |
| Levonorgestrel |
LC/MS/MS |
25-5000 pg/mL |
Human EDTA K2 Plasma |
Current |
Levonorgestrel |
| Levothyroxine (T4) |
LC/MS/MS |
25-250 ng/mL |
Human Serum |
Current |
Levothyroxine (T ) |
| Levothyroxine (T4) |
RIA |
10-250 ng/mL |
Human Serum |
Current |
Levothyroxine (T ) |
| Levothyroxine (T4); Liothyronine(T3) |
LC/MS/MS |
2.5-1000 ng/mL; 0.25-100 ng/mL |
Human Serum |
Current |
Levothyroxine (T ); Liothyronine(T ) |
| Lidocaine |
LC/MS/MS |
200-200000 pg/mL |
Human EDTA Plasma |
Current |
Lidocaine |
| Linezolid |
LC/MS/MS |
100-20000 ng/mL |
Human EDTA Plasma |
Current |
Linezolid |
| Liothyronine |
RIA |
0.5-25 ng/mL |
Human Serum |
Current |
Liothyronine |
| Lisinopril |
LC/MS/MS |
0.5-50 ng/mL |
Human EDTA Plasma |
Current |
Lisinopril |
| Loperamide |
LC/MS/MS |
10-5000 pg/mL |
Human EDTA Plasma |
Current |
Loperamide |
| Loratadine; Descarboethoxy Loratadine |
LC/MS/MS |
20-20000 pg/mL |
Human EDTA Plasma |
Current |
Loratadine; Descarboethoxy Loratadine |
| Lorazepam |
LC/MS/MS |
0.1-30 ng/mL |
Human EDTA Plasma |
Current |
Lorazepam |
| Losartan; Losartan Carboxy Acid |
LC/MS/MS |
1-2000 ng/mL |
Human EDTA Plasma |
Current |
Losartan; Losartan Carboxy Acid |
| Losartan; Losartan Carboxy Acid |
LC/MS/MS |
2-800 ng/mL; 2.5-500 ng/mL |
Human Lithium Heparinized Plasma |
Current |
Losartan; Losartan Carboxy Acid |
| Lovastatin |
LC/MS/MS |
200-10000 pg/mL |
Human EDTA Plasma |
Current |
Lovastatin |
| Lovastatin Hydroxy Acid |
LC/MS/MS |
200-10000 pg/mL |
Human EDTA Plasma |
Current |
Lovastatin Hydroxy Acid |
| Lumefantrine |
LC/MS/MS |
75-15000 ng/mL |
Human EDTA Plasma |
Current |
Lumefantrine |
| Luteinizing Hormone (LH) |
RIA |
3-200 mIU/mL |
Human Serum |
Current |
Luteinizing Hormone (LH) |
| Maraviroc |
LC/MS/MS |
1-1000 ng/mL |
Human EDTA Plasma |
Current |
Maraviroc |
| Medroxyprogesterone Acetate |
GC/MS/MS |
5-2500 pg/mL |
Human Heparinized Plasma |
Current |
Medroxyprogesterone Acetate |
| Medroxyprogesterone Acetate |
LC/MS/MS |
50-10000 pg/mL |
Human EDTA Plasma |
Current |
Medroxyprogesterone Acetate |
| Megestrol Acetate |
LC/MS/MS |
2.5-5000 ng/mL |
Rat EDTA Plasma |
Current |
Megestrol Acetate |
| Megestrol Acetate |
LC/MS/MS |
5-2500 ng/mL |
Human EDTA Plasma |
Current |
Megestrol Acetate |
| Megestrol Acetate; Hydroxymethyl Megestrol; Acetoxy Hydroxymethyl Megestrol; Acetoxy Dihydroxymethyl Megestrol |
LC/MS/MS |
2-500 ng/mL; 1-250 ng/mL; 10-2500 ng/mL; 1-250 ng/mL |
Human EDTA Plasma |
Current |
Megestrol Acetate; Hydroxymethyl Megestrol; Acetoxy Hydroxymethyl Megestrol; Acetoxy Dihydroxymethyl Megestrol |
| Meloxicam |
LC/MS/MS |
10-4000 ng/mL |
Human EDTA Plasma |
Current |
Meloxicam |
| Memantine |
LC/MS/MS |
100-20000 pg/mL |
Human EDTA K2 Plasma |
Current |
Memantine |
| Metaxalone |
LC/MS/MS |
5-8000 ng/mL |
Human EDTA Plasma |
Current |
Metaxalone |
| Metformin |
LC/MS/MS |
10-2500 ng/mL |
Human Urine |
Current |
Metformin |
| Metformin |
LC/MS/MS |
1-400 ng/mL |
Human Plasma |
Current |
Metformin |
| Methadone |
LC/MS/MS |
0.50-100 ng/ml |
Human EDTA Plasma |
Current |
Methadone |
| Methazolamide |
LC/MS/MS |
100-100000 ng/mL |
Human Whole Blood |
Current |
Methazolamide |
| Methazolamide |
LC/MS/MS |
5-10000 ng/mL |
Human EDTA Plasma |
Current |
Methazolamide |
| Methylphenidate and Ritalinic acid |
LC/MS/MS |
0.1-5 ng/mL; 2-100 ng/mL |
Human EDTA Plasma |
Current |
Methylphenidate and Ritalinic acid |
| Methylphenidate and Ritalinic acid |
LC/MS/MS |
0.2-100 ng/mL; 5-2500 ng/mL |
Dog EDTA Plasma |
Current |
Methylphenidate and Ritalinic acid |
| Methylphenidate and Ritalinic acid |
LC/MS/MS |
1-200 ng/mL; 10-2000 ng/mL |
Human Urine |
Current |
Methylphenidate and Ritalinic acid |
| Methylprednisolone |
LC/MS/MS |
0.25-25 ng/mL |
Human Sodium Fluoride/Potassium Oxalate Plasma |
Current |
Methylprednisolone |
| Methylprednisolone |
LC/MS/MS |
0.5-50 ng/mL |
Human EDTA Plasma |
Current |
Methylprednisolone |
| Metoclopramide |
LC/MS/MS |
0.25-100 ng/mL |
Human EDTA Plasma |
Current |
Metoclopramide |
| Metolazone |
LC/MS/MS |
500-150000 pg/mL |
Human Whole Blood |
Current |
Metolazone |
| Metolazone |
LC/MS/MS |
50-25000 pg/mL |
Human EDTA Plasma |
Current |
Metolazone |
| Metoprolol |
LC/MS/MS |
0.25-100 ng/mL |
Human EDTA Plasma |
Current |
Metoprolol |
| Metoprolol (R)-(+) and (S)-(-) |
LC/MS |
100-40000 pg/mL |
Human EDTA Plasma |
Current |
Metoprolol (R) and (S) |
| Mianserin; Normianserin |
LC/MS/MS |
1-200 ng/mL |
Human EDTA Plasma |
Current |
Mianserin; Normianserin |
| Midazolam |
LC/MS/MS |
0.1-100 ng/mL |
Human Whole Blood (DBS) |
Current |
Midazolam |
| Midazolam |
LC/MS/MS |
20-20000 pg/mL |
Human Plasma |
Current |
Midazolam |
| Midazolam; 1-OH-Midazolam |
LC/MS/MS |
0.6-600 ng/mL; 0.1-100 ng/mL |
Human EDTA Plasma |
Current |
Midazolam; OH Midazolam |
| Minocycline |
LC/MS/MS |
20-5000 ng/mL |
Human Lithium Heparinized Plasma |
Current |
Minocycline |
| Mirtazapine |
LC/MS/MS |
1-200 ng/mL |
Human Plasma |
Current |
Mirtazapine |
| Misoprostol Acid |
LC/MS/MS |
10-500 pg/mL |
Human EDTA Plasma |
Current |
Misoprostol Acid |
| Misoprostol Acid |
LC/MS/MS |
40-20000 pg/mL |
Rat EDTA Plasma |
Current |
Misoprostol Acid |
| Mitoxantrone |
LC/MS/MS |
0.5-100 ng/mL |
Human EDTA Plasma |
Current |
Mitoxantrone |
| Modafinil |
LC/MS/MS |
20-4000 ng/mL |
Human EDTA Plasma |
Current |
Modafinil |
| Molsidomine; Linsidomine |
LC/MS/MS |
200-50000 pg/mL |
Human EDTA Plasma |
Current |
Molsidomine; Linsidomine |
| Mometasone Furoate |
LC/MS/MS |
250-50000 pg/mL |
Human Plasma |
Current |
Mometasone Furoate |
| Montelukast |
LC/MS/MS |
2.01-805.76 ng/mL |
Human EDTA Plasma |
Current |
Montelukast |
| Montelukast |
LC/MS/MS |
2-800 ng/mL |
Human Sodium Heparin Plasma |
Current |
Montelukast |
| Morphine |
LC/MS/MS |
0.25-50 ng/mL |
Human EDTA Plasma |
Current |
Morphine |
| Morphine, Morphine-3-Beta-D-Glucuronide, Morphine-6-Beta-D-Glucuronide |
LC/MS/MS |
0.5-250 ng/mL, 10-5000 ng/mL, 1-1000 ng/mL |
Human EDTA Plasma |
Current |
Morphine, Morphine D Glucuronide, Morphine D Glucuronide |
| Morphine; Morphine-6-Glucuronide |
LC/MS/MS |
0.5-100 ng/mL; 2-400 ng/mL |
Human EDTA K3 Plasma |
Current |
Morphine; Morphine Glucuronide |
| Morphine; Morphine 3-Glucuronide; Morphine 6-Glucuronide |
LC/MS/MS |
0.25-50 ng/mL; 5-1000 ng/mL; 1-200 ng/mL |
Human EDTA Plasma |
Current |
Morphine; Morphine Glucuronide; Morphine Glucuronide |
| Morphine; Morphine-3-Glucuronide; Morphine-6-Glucuronide |
LC/MS/MS |
0.5-100 ng/mL; 10-2000 ng/mL; 2.4-400 ng/mL |
Human Heparinized Plasma |
Current |
Morphine; Morphine Glucuronide; Morphine Glucuronide |
| Moxifloxacin |
LC/MS/MS |
10-5000 ng/ml |
Human K2 EDTA Plasma |
New |
Moxifloxacin |
| Moxifloxacin |
LC/MS/MS |
1-100 ug/ml |
Human K2 EDTA Plasma |
New |
Moxifloxacin |
| Moxifloxacin |
LC/MS |
10-5000 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Moxifloxacin |
| Mycophenolate Mofetil |
LC/MS/MS |
20-4000 pg/mL |
Human EDTA Plasma |
Current |
Mycophenolate Mofetil |
| Mycophenolic Acid |
LC/MS/MS |
50-20000 ng/mL |
Human EDTA Plasma |
Current |
Mycophenolic Acid |
| Mycophenolic Acid |
LC/MS/MS |
50-40000 ng/mL |
Human Plasma |
Current |
Mycophenolic Acid |
| Mycophenolic Acid Glucuronide |
LC/MS/MS |
0.5-200 µg/mL |
Human EDTA Plasma |
Current |
Mycophenolic Acid Glucuronide |
| Mycophenolic Acid Glucuronide; Mycophenolic Acid Acyl Glucuronide; Mycophenolic Acid 7-o-beta Glucoside |
LC/MS/MS |
68-68000 ng/mL; 3.4-3400 ng/mL; 4-3400 ng/mL |
Rat Plasma |
Current |
Mycophenolic Acid Glucuronide; Mycophenolic Acid Acyl Glucuronide; Mycophenolic Acid o Glucoside |
| Nabumetone; 6-Methoxy-2-Naphtaleneacetic Acid |
HPLC/FLR |
50-50000 ng/mL |
Human EDTA Plasma |
Current |
Nabumetone; Methoxy Naphtaleneacetic Acid |
| Naftidrofuryl |
HPLC/FLR |
5-1000 ng/mL |
Human EDTA Plasma |
Current |
Naftidrofuryl |
| Naftifine |
LC/MS/MS |
1-1000 ng/mL |
Human Plasma |
Current |
Naftifine |
| Naftifine |
LC/MS/MS |
1-1000 ng/mL |
Human Urine |
Current |
Naftifine |
| Naloxone (Free) |
LC/MS/MS |
5-250 pg/mL |
Human EDTA Plasma |
Current |
Naloxone (Free) |
| Naloxone (Total) |
LC/MS/MS |
50-50000 pg/mL |
Human EDTA K2 Plasma |
Current |
Naloxone (Total) |
| Naloxone; 6-Beta-Hydroxy-Naloxol |
LC/MS/MS |
5-500 pg/mL |
Human Plasma |
Current |
Naloxone; Hydroxy Naloxol |
| Naltrexone; 6-Beta-Naltrexol |
LC/MS/MS |
0.2-50 ng/ml; 0.2-50 ng/ml |
Human K2 EDTA Plasma |
New |
Naltrexone; Naltrexol |
| Naltrexone; 6-Beta-Naltrexol |
LC/MS/MS |
20-2000 pg/mL; 100-50000 pg/mL |
Human Plasma |
Current |
Naltrexone; Naltrexol |
| Naratriptan |
LC/MS/MS |
50-25000 pg/mL |
Human Plasma |
Current |
Naratriptan |
| Nateglinide |
LC/MS/MS |
50-20000 ng/mL |
Human EDTA Plasma |
Current |
Nateglinide |
| Nebivolol |
LC/MS/MS |
20-10000 pg/mL |
Human EDTA Plasma |
Current |
Nebivolol |
| Nefazodone; Hydroxy Nefazodone; M-chlorophenylpiperazin |
LC/MS/MS |
2-500 ng/mL; 0.4-100 ng/mL |
Human EDTA Plasma |
Current |
Nefazodone; Hydroxy Nefazodone; M chlorophenylpiperazin |
| Nevirapine |
LC/MS/MS |
30-3000 ng/mL |
Human EDTA Plasma |
Current |
Nevirapine |
| Niacin |
LC/MS/MS |
25-10000 ng/mL |
Human EDTA Plasma |
Current |
Niacin |
| Niacin |
LC/MS/MS |
50-30000 ng/mL |
Dog Lithium Heparinized Plasma |
Current |
Niacin |
| Niacin; Nicotinuric acid |
LC/MS/MS |
25-10000 ng/mL for both |
Human Plasma |
Current |
Niacin; Nicotinuric acid |
| Nicorandil |
LC/MS/MS |
0.5-200 ng/mL |
Human EDTA Plasma |
Current |
Nicorandil |
| Nicotine |
LC/MS/MS |
1-100 ng/mL |
Human Sodium Heparin Plasma |
Current |
Nicotine |
| Nicotine metabolite: Cotinine |
LC/MS/MS |
10-100 ng/mL |
Human Plasma |
Current |
Nicotine metabolite: Cotinine |
| Nicotinuric Acid |
LC/MS/MS |
2-800 ng/mL |
Human EDTA Plasma |
Current |
Nicotinuric Acid |
| Nifedipine |
LC/MS/MS |
200-100000 pg/mL |
Human EDTA Plasma |
Current |
Nifedipine |
| Nimesulide |
LC/MS |
50-10000 ng/mL |
Human EDTA Plasma |
Current |
Nimesulide |
| Nisoldipine |
LC/MS/MS |
50-50000 pg/mL |
Human EDTA Plasma |
Current |
Nisoldipine |
| Nitrofurantoin |
LC/MS/MS |
1-1000 ng/mL |
Human EDTA Plasma |
Current |
Nitrofurantoin |
| Nizatidine and N-2-Monodesmethylnizatidine |
HPLC/UV |
10-5000 ng/mL; 5-2500 ng/mL |
Human EDTA Plasma |
Current |
Nizatidine and N Monodesmethylnizatidine |
| Nomegestrol Acetate |
LC/MS/MS |
50-20000 pg/mL |
Human EDTA Plasma |
Current |
Nomegestrol Acetate |
| Norethindrone |
LC/MS/MS |
50-10000 pg/mL |
Human EDTA Plasma |
Current |
Norethindrone |
| Norgestimate; 17-Deacetyl Norgestimate; Levonorgestrel |
LC/MS/MS |
100-5000 ng/mL; 50-3000 pg/mL |
Human EDTA Plasma |
Current |
Norgestimate; Deacetyl Norgestimate; Levonorgestrel |
| Nortriptyline; E-10-Hydroxy Nortriptyline |
LC/MS/MS |
1-200 ng/mL |
Human EDTA Plasma |
Current |
Nortriptyline; E Hydroxy Nortriptyline |
| Octreotide |
LC/MS/MS |
50-4000 pg/mL |
Human EDTA Plasma |
Current |
Octreotide |
| Ofloxacin |
HPLC/FLR |
5-5000 ng/mL |
Human EDTA Plasma |
Current |
Ofloxacin |
| Olanzapine |
LC/MS/MS |
0.1-20 ng/mL |
Human EDTA Plasma |
Current |
Olanzapine |
| Olmesartan |
LC/MS/MS |
3-1500 ng/mL |
Human Plasma |
Current |
Olmesartan |
| Omeprazole |
LC/MS/MS |
2-1000 ng/ml |
Human EDTA K2 Plasma |
Current |
Omeprazole |
| Ondansetron |
LC/MS |
10-1000 ng/mL |
Human Lithium Heparin Plasma |
Current |
Ondansetron |
| Ondansetron |
LC/MS/MS |
0.3-300 ng/mL |
Human EDTA K3 Plasma |
Current |
Ondansetron |
| Opipramol |
LC/MS/MS |
100-40000 pg/mL |
Human EDTA Plasma |
Current |
Opipramol |
| Orlistat |
LC/MS/MS |
5-4000 pg/mL |
Human EDTA Plasma |
Current |
Orlistat |
| Oxcarbazepine; 10-Hydroxycarbamazepine |
LC/MS/MS |
4-2000 ng/mL; 20-10000ng/mL |
Human EDTA Plasma |
Current |
Oxcarbazepine; Hydroxycarbamazepine |
| Oxybutynin; N-Desethyloxybutynin |
LC/MS/MS |
50-10000 pg/mL; 100-20000 pg/mL |
Human Plasma |
Current |
Oxybutynin; N Desethyloxybutynin |
| Oxycodone |
LC/MS/MS |
50-12500 pg/mL |
Human Plasma |
Current |
Oxycodone |
| Oxycodone; Oxymorphone; Noroxycodone |
LC/MS/MS |
0.25-125 ng/mL; 40-1600 pg/mL; 0.25-62.5ng/mL |
Human EDTA Plasma |
Current |
Oxycodone; Oxymorphone; Noroxycodone |
| Oxymorphone; 6-OH-Oxymorphone |
LC/MS/MS |
30-6000 pg/ml; 30-3000 pg/ml |
Human EDTA Plasma |
New |
Oxymorphone; OH Oxymorphone |
| Oxypurinol |
LC/MS/MS |
25-2000 ng/mL |
Human EDTA Plasma |
Current |
Oxypurinol |
| Paclitaxel |
LC/MS/MS |
50-10000 ng/mL |
Dog Plasma |
Current |
Paclitaxel |
| Paclitaxel |
LC/MS/MS |
5-5000 ng/mL |
Human EDTA Plasma |
Current |
Paclitaxel |
| Paclitaxel |
LC/MS/MS |
5-5000 ng/mL |
Human Sodium Heparinized Plasma |
Current |
Paclitaxel |
| Paclitaxel; 6-Alpha-Hydroxy Paclitaxel |
LC/MS/MS |
5-5000 ng/mL; 5-500ng/mL |
Human EDTA Plasma |
Current |
Paclitaxel; Alpha Hydroxy Paclitaxel |
| Pantoprazole |
LC/MS/MS |
20-8000 ng/mL |
Human Plasma |
Current |
Pantoprazole |
| Paricalcitol |
LC/MS/MS |
0.5-500 ng/mL |
Rat EDTA K3 Plasma |
Current |
Paricalcitol |
| Paricalcitol |
LC/MS/MS |
10-1000 pg/mL |
Human EDTA Plasma |
Current |
Paricalcitol |
| Paroxetine |
LC/MS/MS |
100-15000 pg/mL |
Human EDTA Plasma |
Current |
Paroxetine |
| Pegasys (Pegylated Interferon Alpha 2A) |
ELISA |
312.5-40000 pg/mL |
Human Serum |
Current |
Pegasys (Pegylated Interferon Alpha A) |
| Pemetrexed |
LC/MS/MS |
1-200 µg/mL |
Human EDTA Plasma |
Current |
Pemetrexed |
| Penciclovir |
LC/MS/MS |
50-10000 ng/mL |
Human EDTA Plasma |
Current |
Penciclovir |
| Pergolide |
LC/MS/MS |
2-50 pg/mL |
Human EDTA Plasma |
Current |
Pergolide |
| Perindopril; Perindoprilat |
LC/MS/MS |
400-160000 pg/mL; 100-40000 pg/mL |
Human EDTA Plasma |
Current |
Perindopril; Perindoprilat |
| Phenobarbital |
LC/MS/MS |
50-5000 ng/mL |
Human EDTA Plasma |
Current |
Phenobarbital |
| Phenylephrine Free |
LC/MS/MS |
10-2500 pg/mL |
Human Plasma |
Current |
Phenylephrine Free |
| Phenytoin |
LC/MS/MS |
25-2500 ng/mL |
Human Plasma |
Current |
Phenytoin |
| Pinaverium |
LC/MS/MS |
5-2500 pg/mL |
Human EDTA Plasma |
Current |
Pinaverium |
| Pioglitazone; Hydroxypioglitazone |
LC/MS/MS |
10-3000 ng/mL; 10-1500 ng/mL |
Human EDTA Plasma |
Current |
Pioglitazone; Hydroxypioglitazone |
| Pioglitazone; Hydroxypioglitazone; Ketopioglitazone |
LC/MS/MS |
10-2000 ng/mL; 20-2000 ng/mL; 4-800 ng/mL |
Human EDTA Plasma |
Current |
Pioglitazone; Hydroxypioglitazone; Ketopioglitazone |
| Piretanide |
LC/MS/MS |
0.5-300 ng/mL |
Human EDTA Plasma |
Current |
Piretanide |
| Posaconazole |
LC/MS/MS |
1-500 ng/mL |
Human EDTA Plasma |
Current |
Posaconazole |
| Potassium |
ICP/MS |
200-40000µg/mL |
Human Urine |
Current |
Potassium |
| Pramipexole |
LC/MS/MS |
10-1000 pg/mL |
Human EDTA Plasma |
Current |
Pramipexole |
| Pravastatin; 3-A-Hydroxy Pravastatin |
LC/MS/MS |
0.25-100 ng/mL; 0.25-50 ng/mL |
Human Lithium Heparinized Plasma |
Current |
Pravastatin; A Hydroxy Pravastatin |
| Pravastatin; 3-A-Hydroxy Pravastatin |
LC/MS/MS |
0.25-100 ng/mL; 0.25-50ng/mL |
Human EDTA Plasma |
Current |
Pravastatin; A Hydroxy Pravastatin |
| Prednisolone |
LC/MS/MS |
1-100 ng/mL |
Rat Plasma |
Current |
Prednisolone |
| Prednisolone |
LC/MS/MS |
1-500ng/mL |
Human EDTA K3 Plasma |
Current |
Prednisolone |
| Prednisone; Prednisolone |
LC/MS/MS |
1-50 ng/mL; 5-250 ng/mL |
Rabbit EDTA K3 Plasma |
Current |
Prednisone; Prednisolone |
| Pregabalin |
LC/MS/MS |
30.07-15036 ng/mL |
Human EDTA Plasma |
Current |
Pregabalin |
| Primidone |
LC/MS/MS |
20-2000 ng/mL |
Human EDTA Plasma |
Current |
Primidone |
| Pristinamycin IA; Pristinamycin IIA |
LC/MS/MS |
2.5-2500 ng/ml; 2.5-2500 ng/ml |
Human Sodium Plasma |
Current |
Pristinamycin IA; Pristinamycin IIA |
| Probenecid; Rifampin |
LC/MS/MS |
250-250000 ng/ml; 10-10000 ng/ml |
Human EDTA Plasma |
New |
Probenecid; Rifampin |
| Progesterone |
LC/MS/MS |
100-50000 pg/mL |
Human EDTA Plasma |
Current |
Progesterone |
| Progesterone |
RIA |
100-40000 pg/mL |
Human Serum |
Current |
Progesterone |
| Promethazine |
LC/MS/MS |
0.5-20 ng/mL |
Human EDTA Plasma |
Current |
Promethazine |
| Propafenone; 5-OH-Propafenone |
LC/MS/MS |
500-500000 pg/mL; 250-250000 pg/mL |
Human EDTA Plasma |
Current |
Propafenone; OH Propafenone |
| Propofol |
LC/MS/MS |
5-5000 ng/mL |
Human Whole Blood |
Current |
Propofol |
| Propranolol Total |
LC/MS/MS |
1-400 ng/mL |
Human EDTA Plasma |
Current |
Propranolol Total |
| Propranolol Total; 4-hydroxypropranolol |
LC/MS/MS |
0.5-100 ng/mL |
Human EDTA Plasma |
Current |
Propranolol Total; hydroxypropranolol |
| Propranolol Total; 4-hydroxypropranolol |
LC/MS/MS |
2-400 ng/mL; 0.5-100 ng/mL |
Human EDTA Plasma |
Current |
Propranolol Total; hydroxypropranolol |
| Propylene glycol |
LC/MS/MS |
1-500 ug/mL |
Human Plasma |
Current |
Propylene glycol |
| Pseudoephedrine |
LC/MS/MS |
3-750 ng/mL |
Human EDTA Plasma |
Current |
Pseudoephedrine |
| Pyridoxal |
LC/MS/MS |
0.5-400 ng/mL |
Human Whole Blood |
Current |
Pyridoxal |
| Pyridoxal-5-Phosphate |
LC/MS/MS |
2-100 ng/mL |
Human Plasma |
Current |
Pyridoxal Phosphate |
| Pyridoxamine |
LC/MS/MS |
200-50000 pg/mL |
Human Blood |
Current |
Pyridoxamine |
| Pyridoxamine |
LC/MS/MS |
200-50000 pg/mL |
Human Plasma |
Current |
Pyridoxamine |
| Pyridoxamine 5-Phosphate |
LC/MS/MS |
500-50000 pg/mL |
Human Blood |
Current |
Pyridoxamine Phosphate |
| Pyridoxine |
LC/MS/MS |
0.25-200 ng/mL |
Human Plasma |
Current |
Pyridoxine |
| Quetiapine |
LC/MS/MS |
0.5-125 ng/mL |
Human EDTA Plasma |
Current |
Quetiapine |
| Quetiapine |
LC/MS/MS |
2-150ng/mL |
Human Sodium Heparinized Plasma |
Current |
Quetiapine |
| Quinapril; Quinaprilat |
LC/MS/MS |
2-200 ng/mL; 2.5-1000 ng/mL |
Human EDTA Plasma |
Current |
Quinapril; Quinaprilat |
| Quinidine |
LC/MS/MS |
40-4000 ng/mL |
Human EDTA Plasma |
Current |
Quinidine |
| Quinine |
LC/MS/MS |
10-2000 ng/mL |
Human EDTA Plasma |
Current |
Quinine |
| R-Selegiline |
LC/MS/MS |
50-5000 ng/mL |
Human EDTA Plasma |
Current |
R Selegiline |
| R-Selegiline, N-Desmethyl Selegiline, L-Amphetamine; L-Methamphetamine |
LC/MS/MS |
10-10000 pg/mL; 50-5000 pg/mL; 20-8000 pg/mL; 20-8000 pg/mL |
Rat Plasma |
Current |
R Selegiline, N Desmethyl Selegiline, L Amphetamine; L Methamphetamine |
| R-Selegiline, N-Desmethyl Selegiline, L-Amphetamine; L-Methamphetamine |
LC/MS/MS |
40-8000 pg/mL; 100-20000 pg/mL; 50-20000 pg/mL; 50-20000 pg/mL |
Human Urine |
Current |
R Selegiline, N Desmethyl Selegiline, L Amphetamine; L Methamphetamine |
| R-Selegiline, N-Desmethyl Selegiline, L-Amphetamine; L-Methamphetamine |
LC/MS/MS |
50-5000 pg/mL; 25-2500 pg/mL; 20-2500pg/mL; 15-6000 pg/mL |
Human EDTA Plasma |
Current |
R Selegiline, N Desmethyl Selegiline, L Amphetamine; L Methamphetamine |
| R/S-Zopiclone (Chiral Method) |
LC/MS/MS |
1-100 ng/mL |
Human EDTA Plasma |
Current |
R/S Zopiclone (Chiral Method) |
| Rabeprazole |
LC/MS/MS |
2-1000 ng/mL |
Human EDTA Plasma |
Current |
Rabeprazole |
| Racecadotril |
LC/MS/MS |
10-5000 pg/mL |
Human Plasma |
Current |
Racecadotril |
| Raloxifene |
LC/MS/MS |
10-500 pg/mL |
Human EDTA Plasma |
Current |
Raloxifene |
| Raloxifene-4'-Glucuronide; Raloxifene-6-Glucuronide |
LC/MS/MS |
2 - 200 ng/mL; 0.4 - 40 ng/mL |
Human EDTA Plasma |
Current |
Raloxifene ' Glucuronide; Raloxifene Glucuronide |
| Ramipril; Ramiprilat |
LC/MS/MS |
100-40000 pg/mL |
Human EDTA Plasma |
Current |
Ramipril; Ramiprilat |
| Ranitidine |
LC/MS/MS |
4-1600 ng/mL |
Human EDTA Plasma |
Current |
Ranitidine |
| Rasagiline |
LC/MS/MS |
10-10000 pg/mL |
Human EDTA Plasma |
Current |
Rasagiline |
| Rebif |
ELISA |
5-200 pg/mL |
Human Serum |
Current |
Rebif |
| Repaglinide |
LC/MS/MS |
100-25000 pg/mL |
Human EDTA Plasma |
Current |
Repaglinide |
| Repaglinide; Hydroxy-Repaglinide (M4) |
LC/MS/MS |
50-50000 pg/mL; 50-50000 pg/mL |
Human EDTA Plasma |
Current |
Repaglinide; Hydroxy Repaglinide (M ) |
| Rhein |
LC/MS/MS |
50-5000 ng/mL |
Human EDTA Plasma |
Current |
Rhein |
| Ribavirin |
LC/MS/MS |
10-5000 ng/mL |
Human EDTA Plasma |
Current |
Ribavirin |
| Rifampin |
LC/MS/MS |
0.5-50 ng/mL |
Human EDTA Whole Blood |
Current |
Rifampin |
| Rifampin |
LC/MS/MS |
50-12500 ng/mL |
Human Whole Blood |
Current |
Rifampin |
| Rifaximin |
LC/MS/MS |
20-2000 pg/mL |
Human Plasma |
Current |
Rifaximin |
| Riluzole |
LC/MS/MS |
0.5-500 ng/mL |
Human EDTA Plasma |
Current |
Riluzole |
| Risedronic Acid |
LC/MS/MS |
50-50000 pg/mL |
Human EDTA Plasma |
Current |
Risedronic Acid |
| Risperidone; 9-Hydroxyrisperidone |
LC/MS/MS |
100-50000 pg/mL; 100-25000 pg/mL |
Human EDTA Plasma |
Current |
Risperidone; Hydroxyrisperidone |
| Ritalinic Acid |
LC/MS/MS |
1-250 ng/mL |
Human EDTA Plasma |
Current |
Ritalinic Acid |
| Ritonavir |
LC/MS/MS |
5-1000 ng/mL |
Human EDTA Plasma |
Current |
Ritonavir |
| Rivastigmine |
LC/MS/MS |
40-4000 pg/mL |
Human EDTA Plasma |
Current |
Rivastigmine |
| Rizatriptan |
LC/MS/MS |
100-40000 pg/mL |
Human EDTA Plasma |
Current |
Rizatriptan |
| Rizatriptan; N-Desmethyl Rizatrptan |
LC/MS/MS |
100-40000 pg/mL;10-4000 pg/mL |
Human EDTA Plasma |
Current |
Rizatriptan; N Desmethyl Rizatrptan |
| Ropinirole |
LC/MS/MS |
1-50ng/mL |
Rabbit EDTA K3 Plasma |
Current |
Ropinirole |
| Ropinirole |
LC/MS/MS |
5-1000 pg/mL |
Human EDTA Plasma |
Current |
Ropinirole |
| Rosiglitazone |
LC/MS/MS |
2-900 ng/mL |
Human EDTA Plasma |
Current |
Rosiglitazone |
| Rosuvastatin |
LC/MS/MS |
80-40000 pg/mL |
Human EDTA Plasma |
Current |
Rosuvastatin |
| S-(+)-Ibuprofen; R-(-)-Ibuprofen |
LC/MS/MS |
100-20000 ng/mL |
Human EDTA Plasma |
Current |
S Ibuprofen; R Ibuprofen |
| S-Citalopram; S-Desmethyl Citalopram |
LC/MS/MS |
200-200,000 pg/mL |
Human EDTA K3 Plasma |
Current |
S Citalopram; S Desmethyl Citalopram |
| Saxagliptin; 5-Hydroxy-Saxagliptin |
LC/MS/MS |
100-50000 pg/mL; 200-100000 pg/mL |
Human EDTA Plasma |
Current |
Saxagliptin; Hydroxy Saxagliptin |
| Scopolamine |
LC/MS/MS |
50-10000 pg/mL |
Human Plasma |
Current |
Scopolamine |
| Scopolamine N-Butyl |
LC/MS/MS |
10-5000 pg/mL |
Human EDTA K2 Plasma |
Current |
Scopolamine N Butyl |
| Sertraline |
LC/MS/MS |
0.25-75 ng/mL |
Human EDTA Plasma |
Current |
Sertraline |
| Sibutramine; N-Mono-Desmethyl-Sibutramine; N-Didesmethyl-Sibutramine |
LC/MS/MS |
50-12500 pg/mL; 100-5000 pg/mL; 100-10000pg/mL |
Human Sodium Heparinized Plasma |
Current |
Sibutramine; N Mono Desmethyl Sibutramine; N Didesmethyl Sibutramine |
| Sibutramine; N-Mono-Desmethyl-Sibutramine; N-Didesmethyl-Sibutramine |
LC/MS/MS |
50-25000 pg/mL; 100-50000pg/mL; 100-50000pg/mL |
Human Heparin Plasma |
Current |
Sibutramine; N Mono Desmethyl Sibutramine; N Didesmethyl Sibutramine |
| Sildenafil; Desmethyl Sildenafil |
LC/MS/MS |
1-250 ng/mL; 0.5-125 ng/mL |
Human EDTA Plasma |
Current |
Sildenafil; Desmethyl Sildenafil |
| Silodosin; Silodosin-O-Beta-D-Glucuronide |
LC/MS/MS |
0.5-125 ng/mL; 0.5-125 ng/mL |
Human EDTA Plasma |
Current |
Silodosin; Silodosin O D Glucuronide |
| Simvastatin; Beta-Hydroxy Acid Simvastatin |
LC/MS/MS |
100-20000 pg/mL; 100-5000 pg/nL |
Human EDTA Plasma |
Current |
Simvastatin; Hydroxy Acid Simvastatin |
| Sirolimus |
LC/MS/MS |
50-20000 pg/mL |
Human Whole Blood |
Current |
Sirolimus |
| Sitagliptin |
LC/MS/MS |
0.5-1000 ng/mL |
Human EDTA Plasma |
Current |
Sitagliptin |
| Solifenacin |
LC/MS/MS |
100-100000 pg/mL |
Human EDTA Plasma |
Current |
Solifenacin |
| Sorafenib |
LC/MS/MS |
10-10000 ng/mL |
Human Lithium Heparinized Plasma |
Current |
Sorafenib |
| Sorafenib |
LC/MS/MS |
10-5000 ng/mL |
Human EDTA K2 Plasma |
Current |
Sorafenib |
| Spironolactone |
LC/MS/MS |
1-200 ng/mL |
Human EDTA Plasma |
Current |
Spironolactone |
| Spironolactone and Canrenone |
LC/MS/MS |
0.5-100 ng/mL |
Human EDTA Plasma |
Current |
Spironolactone and Canrenone |
| Stavudine |
LC/MS/MS |
2.5-2000 ng/mL |
Human EDTA Plasma |
Current |
Stavudine |
| Strontium Ralenate |
ICP/MS |
100-20000 ng/ml |
Human Lithium Heparinized Plasma |
Current |
Strontium Ralenate |
| Sumatriptan |
LC/MS/MS |
0.5-50 ng/mL |
Human EDTA Plasma |
Current |
Sumatriptan |
| Sunitinib; N-Desethyl-Sunitinib |
LC/MS/MS |
0.25-100 ng/mL |
Human EDTA Plasma |
Current |
Sunitinib; N Desethyl Sunitinib |
| Synephrine |
LC/MS/MS |
1-100 ng/mL |
Human EDTA Plasma |
Current |
Synephrine |
| Tacrolimus |
LC/MS/MS |
50-50000 pg/mL |
Whole blood |
Current |
Tacrolimus |
| Tadalafil |
LC/MS/MS |
5-2500 ng/mL |
Human EDTA Plasma |
Current |
Tadalafil |
| Tamoxifen |
LC/MS/MS |
0.5-100 ng/mL |
Human EDTA Plasma |
Current |
Tamoxifen |
| Tamoxifen; 4-Hydroxy-Tamoxifen; N-Desmethyl-Tamoxifen; 4-Hydroxy-N-Desmethyl-Tamoxifen |
LC/MS/MS |
0.25-100ng/ml; 0.1-40ng/ml, 0.25-100ng/ml; 0.1-40ng/ml |
Human EDTA Plasma |
Current |
Tamoxifen; Hydroxy Tamoxifen; N Desmethyl Tamoxifen; Hydroxy N Desmethyl Tamoxifen |
| Tamoxifen; N-Desmethyl-Tamoxifen |
LC/MS/MS |
0.5-50 ng/mL; 0.5-25 ng/mL |
Human EDTA Plasma |
Current |
Tamoxifen; N Desmethyl Tamoxifen |
| Tamsulosin |
LC/MS/MS |
100-30000 pg/mL |
Human EDTA Plasma |
Current |
Tamsulosin |
| Telmisartan |
LC/MS/MS |
1-500 ng/mL |
Human EDTA Plasma |
Current |
Telmisartan |
| Temozolomide |
LC/MS/MS |
100-25000 ng/mL |
Human Plasma |
Current |
Temozolomide |
| Tenofovir |
LC/MS/MS |
0.5-500 ng/mL |
Human Serum |
Current |
Tenofovir |
| Terbinafine |
LC/MS/MS |
10-5000 ng/mL |
Human Nails |
Current |
Terbinafine |
| Terbinafine |
LC/MS/MS |
1-500 ng/mL |
Rat EDTA Plasma |
Current |
Terbinafine |
| Terbinafine |
LC/MS/MS |
25-12500 pg/mL |
Human EDTA Plasma |
Current |
Terbinafine |
| Teriflunomide |
LC/MS/MS |
30-3000 ng/mL |
Human EDTA Plasma |
Current |
Teriflunomide |
| Testosterone |
GC/MS/MS |
25-3200 pg/mL |
Human Heparin Plasma |
Current |
Testosterone |
| Testosterone |
LC/MS/MS |
5-5000 ng/Tip |
Polyester-tipped Applicators |
Current |
Testosterone |
| Testosterone |
LC/MS/MS |
60-12000 pg/mL |
Human Serum |
Current |
Testosterone |
| Testosterone Undecanoate; Dihydrotestosterone Undecanoate |
LC/MS/MS |
1-500 ng/mL; 0.5-250 ng/mL |
Human Sodium Fluoride/Potassium Oxalate Plasma |
Current |
Testosterone Undecanoate; Dihydrotestosterone Undecanoate |
| Testosterone; Dihydrotestosterone |
LC/MS/MS |
50-10000 pg/mL |
Human Sodium Fluoride/Potassium Oxalate Plasma |
Current |
Testosterone; Dihydrotestosterone |
| Theophylline |
LC/MS/MS |
20-20,000 ng/mL |
Human EDTA Plasma |
Current |
Theophylline |
| Thiorphan |
LC/MS/MS |
0.5-250 ng/mL |
Human Plasma |
Current |
Thiorphan |
| Thromboxane B2 |
LC/MS/MS |
10 -10000 pg/mL |
Human Serum |
Current |
Thromboxane B |
| Tiagabine |
LC/MS/MS |
0.5-1000 ng/ml |
Human EDTA Plasma |
Current |
Tiagabine |
| Tibolone |
LC/MS/MS |
25-5000 pg/mL |
Human EDTA Plasma |
Current |
Tibolone |
| Tibolone Delta-4 |
LC/MS/MS |
75-2500 pg/mL |
Human EDTA Plasma |
Current |
Tibolone Delta |
| Tibolone; 3-Alpha Hydroxytibolone; 3-Beta Hydroxytibolone |
GC/MS |
100-20000 pg/mL |
Human EDTA Plasma |
Current |
Tibolone; Hydroxytibolone; Hydroxytibolone |
| Ticlopidine |
LC/MS/MS |
1-1000 ng/mL |
Human EDTA Plasma |
Current |
Ticlopidine |
| Tinidazole |
LC/MS/MS |
40-40000 ng/mL |
Human EDTA Plasma |
Current |
Tinidazole |
| Tizanidine |
LC/MS/MS |
1-500 ng/mL |
Rat EDTA Plasma |
Current |
Tizanidine |
| Tizanidine |
LC/MS/MS |
50-25000 pg/mL |
Dog EDTA Plasma |
Current |
Tizanidine |
| Tizanidine |
LC/MS/MS |
50-8000 pg/mL |
Human EDTA Plasma |
Current |
Tizanidine |
| Tizanidine; Tizanidine-M4 |
LC/MS/MS |
50-2500pg/mL; 100-50000 pg/mL |
Human EDTA Plasma |
Current |
Tizanidine; Tizanidine M |
| Tobramycin |
LC/MS/MS |
0.5-50 µg/mL |
Human Sputum |
Current |
Tobramycin |
| Tobramycin |
LC/MS/MS |
20-1000 ng/mL |
Human Serum |
Current |
Tobramycin |
| Tolterodine; 5-Hydroxymethyl Tolterodine |
LC/MS/MS |
49.90-9980; 50-10000 pg/mL |
Human Plasma |
Current |
Tolterodine; Hydroxymethyl Tolterodine |
| Topiramate |
GC/MS |
10-1500 ng/mL |
Human EDTA Plasma |
Current |
Topiramate |
| Topiramate |
LC/MS/MS |
0.1-20 ug/mL |
Human Urine |
Current |
Topiramate |
| Topiramate |
LC/MS/MS |
10-1000 ng/mL |
Human Plasma |
Current |
Topiramate |
| Torsemide |
HPLC/UV |
100-20000 ng/mL |
Human EDTA Plasma |
Current |
Torsemide |
| Torsemide |
LC/MS/MS |
0.5 -200; 100-25,000ng/mL |
Human EDTA Plasma |
Current |
Torsemide |
| Torsemide |
LC/MS/MS |
0.5-200; 100-10,000ng/mL |
Human Urine |
Current |
Torsemide |
| Tramadol |
LC/MS/MS |
1-400 ng/mL |
Human Plasma |
Current |
Tramadol |
| Tramadol; Metabolite Chiral |
LC/MS/MS |
0.5-100 ng/mL; 0.25-25 ng/mL |
Human EDTA Plasma |
Current |
Tramadol; Metabolite Chiral |
| Tramadol; O-Desmethyltramadol |
LC/MS/MS |
0.5-200 ng/mL; 0.5-50 ng/mL |
Human EDTA Plasma |
Current |
Tramadol; O Desmethyltramadol |
| Trandolapril; Trandolaprilat |
LC/MS/MS |
25-1000 pg/mL; 50-2000 pg/mL |
Human EDTA Plasma |
Current |
Trandolapril; Trandolaprilat |
| Tranylcypromine |
LC/MS |
1-50 ng/mL |
Human EDTA Plasma |
Current |
Tranylcypromine |
| Trazodone |
LC/MS/MS |
10-2,000 ng/mL |
Human Lithium Heparinized Plasma |
Current |
Trazodone |
| Triamcinolone Acetonide |
LC/MS/MS |
100-8000 pg/mL |
Human EDTA Plasma |
Current |
Triamcinolone Acetonide |
| Triamcinolone Acetonide |
LC/MS/MS |
50-5000 pg/ml |
Rabbit EDTA Plasma |
Current |
Triamcinolone Acetonide |
| Trimetazidine |
LC/MS/MS |
1-200 ng/mL |
Human EDTA Plasma |
Current |
Trimetazidine |
| Trospium |
LC/MS/MS |
4-2000 pg/mL |
Human EDTA Plasma |
Current |
Trospium |
| Tucaresol |
LC/MS/MS |
75-15000 ng/mL |
Human EDTA Plasma |
Current |
Tucaresol |
| Urapidil |
LC/MS/MS |
1-1000 ng/ml |
Human EDTA Plasma |
New |
Urapidil |
| Ursodiol; Tauroursodeoxycholic Acid; Glycoursodeoxycholic Acid |
LC/MS/MS |
6-6000; 0.5-250; 12-6000 ng/mL |
Human EDTA Plasma |
Current |
Ursodiol; Tauroursodeoxycholic Acid; Glycoursodeoxycholic Acid |
| Valacyclovir |
LC/MS/MS |
1-400 ng/mL |
Human EDTA Plasma |
Current |
Valacyclovir |
| Valproic Acid |
LC/MS/MS |
0.5-100 µg/mL |
Human EDTA Plasma |
Current |
Valproic Acid |
| Valproic Acid |
LC/MS/MS |
1-100µg/mL |
Human Serum |
Current |
Valproic Acid |
| Valproic Acid |
LC/MS/MS |
1-100µg/mL |
Human Urine |
Current |
Valproic Acid |
| Valsartan |
LC/MS/MS |
20-10000 ng/mL |
Human EDTA Plasma |
Current |
Valsartan |
| Vardenefil |
LC/MS/MS |
80-40000 pg/mL |
Human Plasma |
Current |
Vardenefil |
| Venlafaxine; O-Desmethylvenlafaxine |
LC/MS/MS |
1-200 ng/mL; 2-200 ng/mL |
Human EDTA Plasma |
Current |
Venlafaxine; O Desmethylvenlafaxine |
| Vildagliptin |
LC/MS/MS |
1-2000 ng/mL |
Human EDTA Plasma |
Current |
Vildagliptin |
| Vinorelbine |
LC/MS/MS |
1-1000 ng/mL |
Human EDTA Plasma |
Current |
Vinorelbine |
| Voriconazole |
LC/MS/MS |
5-2000 ng/mL |
Human EDTA Plasma |
Current |
Voriconazole |
| Warfarin |
HPLC/FLR |
20-1500 ng/mL |
Human EDTA Plasma |
Current |
Warfarin |
| Zaleplon |
LC/MS/MS |
100-45000 pg/mL |
Human EDTA Plasma |
Current |
Zaleplon |
| Zanamivir |
LC/MS/MS |
10-10000 ng/ml |
Human Serum |
Current |
Zanamivir |
| Zanamivir |
LC/MS/MS |
10-650 µg/ml |
Human Urine |
Current |
Zanamivir |
| Zidovudine |
LC/MS/MS |
2-4000 ng/mL |
Human EDTA Plasma |
Current |
Zidovudine |
| Ziprasidone |
LC/MS/MS |
0.25-250 ng/mL |
Human EDTA Plasma |
Current |
Ziprasidone |
| Zoledronic Acid |
LC/MS/MS |
1-250 ng/mL |
Human Serum |
Current |
Zoledronic Acid |
| Zoledronic Acid |
LC/MS/MS |
1-250 ng/mL |
Human Urine |
Current |
Zoledronic Acid |
| Zolmitriptan; N-Desmethylzolmitriptan |
LC/MS/MS |
100-20000 pg/mL; 50-10000 pg/mL |
Human EDTA Plasma |
Current |
Zolmitriptan; N Desmethylzolmitriptan |
| Zolpidem |
LC/MS/MS |
1-250 ng/mL |
Human EDTA Plasma |
Current |
Zolpidem |
| Zonisamide |
LC/MS/MS |
20-2500 ng/mL |
Human EDTA Plasma |
Current |
Zonisamide |
| Zonisamide |
LC/MS/MS |
25-5000 ng/mL |
Human Whole Blood |
Current |
Zonisamide |
| Zonisamide |
LC/MS/MS |
50-2500 ng/mL |
Human Serum |
Current |
Zonisamide |
| Zopiclone |
LC/MS/MS |
0.3-150 ng/ml |
Human EDTA Plasma |
New |
Zopiclone |